David Segal, PhD
I have been an academic researcher in the Angelman field since 2007. I am developing two therapeutic approaches, and have been an author on 15 publications.
Board Member
Professor
University of California, Davis
Specialties: Genomic therapeutics
Email: djsegal@ucdavis.edu
David Segal received his Ph.D. from the University of Utah performed a post-doc at The Scripps Research Institute. Now at UC Davis, Dr. Segal’s research focuses on gene and epigenome editing to treat Angelman syndrome and related neurologic disorders. He is a founding member of the Interventional Genetics Program at the UC Davis MIND Institute, an investigator in the NIH Somatic Cell Genome Editing Consortium, and Editor-in-Chief of Frontiers in Genome Editing.